{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:54:28Z","timestamp":1788018868027,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112007","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:56:48Z","timestamp":1628539008000},"page":"112007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice"],"prefix":"10.1016","volume":"142","author":[{"given":"Adela","family":"Garc\u00eda-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Garrido-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E.","family":"Prados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Caprioglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Appendino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112007_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fphys.2017.00777","article-title":"The processes and mechanisms of cardiac and pulmonary fibrosis","volume":"8","author":"Murtha","year":"2017","journal-title":"Front Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib2","first-page":"e38","article-title":"C. American Heart Association Statistics, S. Stroke Statistics, Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Writing Group","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2021.112007_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2010.02.047","article-title":"Assessment of nonischemic myocardial fibrosis","volume":"56","author":"Jellis","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112007_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tcm.2017.01.011","article-title":"Myocardial fibrosis predicts ventricular tachyarrhythmias","volume":"27","author":"Disertori","year":"2017","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.biopha.2021.112007_bib6","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1253\/circj.CJ-16-1003","article-title":"Defining the cardiac fibroblast","volume":"80","author":"Ivey","year":"2016","journal-title":"Circ. J."},{"issue":"9568","key":"10.1016\/j.biopha.2021.112007_bib7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0906-6705.2004.0139.x","article-title":"Human skin: source of and target organ for angiotensin II","volume":"13","author":"Steckelings","year":"2004","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2021.112007_bib10","doi-asserted-by":"crossref","first-page":"15561","DOI":"10.1038\/srep15561","article-title":"Chronic activation of the renin-angiotensin system induces lung fibrosis","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"3 Pt 2","key":"10.1016\/j.biopha.2021.112007_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"Mezzano","year":"2001","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0008-6363(95)00214-6","article-title":"Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin","volume":"31","author":"Sigusch","year":"1996","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.biopha.2021.112007_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/01.RES.86.12.1187","article-title":"Cytokine actions of angiotensin II","volume":"86","author":"Sadoshima","year":"2000","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2021.112007_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphys.2014.00396","article-title":"Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation","volume":"5","author":"Gomolak","year":"2014","journal-title":"Front Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112007_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharm. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/labinvest.2010.190","article-title":"Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells","volume":"91","author":"Sopel","year":"2011","journal-title":"Lab. Investig."},{"issue":"8","key":"10.1016\/j.biopha.2021.112007_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.ATV.0000021412.56621.A2","article-title":"Vascular inflammation and the renin-angiotensin system","volume":"22","author":"Brasier","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.HYP.0000138688.78906.6b","article-title":"Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling","volume":"44","author":"Zhao","year":"2004","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.biopha.2021.112007_bib19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00018-018-2995-5","article-title":"Immune responses in cardiac repair and regeneration: a comparative point of view","volume":"76","author":"Lai","year":"2019","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112007_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112007_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41467-019-14263-2","article-title":"Macrophages directly contribute collagen to scar formation during zebrafish heart regeneration and mouse heart repair","volume":"11","author":"Simoes","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2021.112007_bib22","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db07-0924","article-title":"Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis","volume":"57","author":"Caglayan","year":"2008","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2021.112007_bib23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hc1002.105225","article-title":"Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo","volume":"105","author":"Asakawa","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2021.112007_bib24","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/art.27642","article-title":"Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis","volume":"62","author":"Marquart","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2021.112007_bib25","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1038\/srep21703","article-title":"The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-\u03b3 and CB2 pathways","volume":"6","author":"del R\u00edo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112007_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2018.07.047","article-title":"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis","volume":"157","author":"Garcia-Martin","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112007_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcp.2019.02.029","article-title":"Cannabinoid derivatives acting as dual PPARgamma\/CB2 agonists as therapeutic agents for systemic sclerosis","volume":"163","author":"Garcia-Martin","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2021.112007_bib28","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.bmc.2014.04.062","article-title":"Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity","volume":"22","author":"Tepper","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib29","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.172.4.2341","article-title":"Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways","volume":"172","author":"Sancho","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"issue":"17","key":"10.1016\/j.biopha.2021.112007_bib31","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.biopha.2021.112007_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.biopha.2021.112007_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.biopha.2021.112007_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"issue":"11","key":"10.1016\/j.biopha.2021.112007_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tibs.2004.09.002","article-title":"The biochemical response of the heart to hypertension and exercise","volume":"29","author":"Wakatsuki","year":"2004","journal-title":"Trends Biochem Sci."},{"issue":"5","key":"10.1016\/j.biopha.2021.112007_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.63.5.983","article-title":"Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid","volume":"63","author":"Liu","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112007_bib38","first-page":"521","article-title":"The role of E2F1 in the development of hypertrophic cardiomyopathy","volume":"4","author":"Wolfram","year":"2011","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112007_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-018-1103-y","article-title":"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy","volume":"15","author":"Navarrete","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.biopha.2021.112007_bib40","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanus","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2021.112007_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.physiol.59.1.395","article-title":"Biological functions of angiotensin and its receptors","volume":"59","author":"Matsusaka","year":"1997","journal-title":"Annu Rev. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112007_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/labinvest.2008.104","article-title":"PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta","volume":"89","author":"Kawai","year":"2009","journal-title":"Lab. Investig."},{"issue":"7","key":"10.1016\/j.biopha.2021.112007_bib43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/01902148.2018.1543368","article-title":"CB2R agonist prevents nicotine induced lung fibrosis","volume":"44","author":"Wawryk-Gawda","year":"2018","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.biopha.2021.112007_bib44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2021.112007_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmed.2020.00047","article-title":"Advances in understanding the effects of erythropoietin on renal fibrosis","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000178","article-title":"Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling","volume":"2","author":"Ikeda","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.biopha.2021.112007_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FJC.0b013e3181e2bfef","article-title":"Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat","volume":"56","author":"Bao","year":"2010","journal-title":"J. Cardiovasc. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20061943","article-title":"Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice","volume":"204","author":"Jiang","year":"2007","journal-title":"J. Exp. Med"},{"issue":"8","key":"10.1016\/j.biopha.2021.112007_bib49","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/art.41302","article-title":"Lenabasum for skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"72","author":"Hinchcliff","year":"2020","journal-title":"Arthritis Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2021.112007_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/HYPERTENSIONAHA.118.12286","article-title":"Novel role of T cells and IL-6 (Interleukin-6) in angiotensin II-induced microvascular dysfunction","volume":"73","author":"Senchenkova","year":"2019","journal-title":"Hypertension"},{"issue":"13","key":"10.1016\/j.biopha.2021.112007_bib51","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2017.07.789","article-title":"Bone marrow-derived tenascin-C attenuates cardiac hypertrophy by controlling inflammation","volume":"70","author":"Song","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2021.112007_bib52","doi-asserted-by":"crossref","first-page":"40342","DOI":"10.1038\/srep40342","article-title":"CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts","volume":"7","author":"Tang","year":"2017","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.biopha.2021.112007_bib53","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1101\/gad.12.15.2245","article-title":"The regulation of E2F by pRB-family proteins","volume":"12","author":"Dyson","year":"1998","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.biopha.2021.112007_bib54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1997.0620","article-title":"Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes","volume":"30","author":"Flink","year":"1998","journal-title":"J. Mol. Cell Cardiol."},{"issue":"24","key":"10.1016\/j.biopha.2021.112007_bib55","doi-asserted-by":"crossref","first-page":"21388","DOI":"10.1074\/jbc.M212612200","article-title":"Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy","volume":"278","author":"Vara","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:28:13Z","timestamp":1760099293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221007903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":55,"alternative-id":["S0753332221007903"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112007","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112007"}}